are ginkgo bioworks’ acquisitions of bayer, zymergen, and related companies, actually strategic?
Published 1 month ago • 26 plays • Length 3:27Download video MP4
Download video MP3
Similar videos
-
3:44
how have ginkgo bioworks’ acquisitions of other companies been strategic?
-
3:30
how is ginkgo bioworks expecting to get out of this?
-
4:52
is ginkgo bioworks’ change to intellectual property the largest blow to investor confidence?
-
2:50
🤔 what does cathie wood think of ginkgo bioworks?
-
4:06
😫 all eyes are on jason kelly, ceo of ginkgo bioworks
-
24:12
tips & advice for developing ginkgo as bonsai.
-
11:11
how to grow a ginkgo tree from seed (maidenhair tree)
-
3:30
is it only a matter of time before ginkgo bioworks stock hits a penny?
-
2:18
at $9.31, ginkgo bioworks is still essentially a penny stock
-
2:57
how is ginkgo bioworks still at -$468.13 million in “adjusted” ebitda?
-
8:02
what was ginkgo bioworks’ $1.6 billion ipo good for?
-
7:27
looking at the history of ginkgo bioworks since ipo
-
3:52
how have q2 2024 results from ginkgo bioworks been received?
-
3:08
is the nyse losing patience with ginkgo bioworks stock?
-
2:41
🤔 how does ginkgo bioworks, and other tech companies, decide who to include in a mass layoff?
-
7:26
is ginkgo bioworks making any changes to its break even strategy?
-
4:09
🤔 what is the true potential of ginkgo bioworks’ “next generation” biofab1 facility?
-
3:34
how has gross stock compensation at ginkgo bioworks exceeded $2 billion?
-
2:10
🤔 how did ginkgo bioworks stock go from $14 to 30 cents?
-
2:47
how long did it take ginkgo bioworks stock to drop by 10 cents?